3Milliez P, Girerd X, Plousin PF,et al. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism[J]. J Am Coll Cardiol,2005,45(8):1 243-1 248.
2MULATERO P,STOWASSER M, LOH K C.Increased diagnosis of primary aldosteronism,including surgically correctable forms,in centers from five continents[J]. J Clin Endocrinol Metab,2004,89(3):1045-1050.
3YOUNG W F Jr.Minireview:primary aldosteronism-changing concepts in diagnosis and treatment[J]. Endocrinology,2003,144(6):2208-2213.
4STRUTHERS A D. Aldosterone-induced vasculopathy[J]. Molecular and Cellular Endocrinology,2004,217(1-2):239-241.
5ROSSI G P, DI B V, GANZAROLI C, et al. Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism[J]. Hypertension,2002,40(1):23-27.
6MILLIEZ P,GIRERD X,PLOUIN P F.Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism[J]. J Am Coll Cardiol,2005,45(8):1243-1248.
7STOWASSER M, GORDON R D. Primary aldosteronism-careful investigation is essential and rewarding[J]. Molecular and Cellular Endocrinology,2004,217(1-2):33-39.
8STOWASSER M,GORDON R D,GUNASEKERA T G,et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after ‘non-selective' screening of hypertensive patients[J]. J Hypertens,2003,21(11):2149-2157.
9CONN J W, COHEN E L,ROVNER D R,et al. Normokalemic primary aldosteronism. A detectable cause of curable “essential” hypertension[J]. JAMA,1965,19(193):200-206.
10ROSSI E, REGOLISTI G, NEGRO A, et al. High prevalence of primary aldosteronism using postcaptopril plasma aldosterone to renin ratio as a screening test among Italian hypertensives[J]. Am J Hypertens,2002,15(10 Pt 1):896-902.
3Schulick R D, Brennan M F. Long-term survival after complete resection and repeat resection in patients with adrenocortical carcinoma[J]. Ann Surg Oncol , 1999, 6 (8): 719-726.
4Chouairy C J, Abdul-Karim F, MacLennan G T. Adrenocortical carcinoma [J]. J Urol, 2008, 179 (1) : 323.
5Kuruba R, Gallagher S F. Current management of adrenal tumors[J]. Curr Opin Oneal, 2008, 20 (1): 34- 46.
6Assie G, Antoni G, Tissier F, et al. Prognostic parameters of metastatic adrenocortical carcinoma [J]. J Clin Endocrinol Metab , 2007, 92(1): 148-154.
7Wajchenberg B L, Albergaria Pereira M A, Medonca B B, et al. Adrenocortical carcinoma: clinical and laboratory observations [J]. Cancer, 2000, 88 (4): 711- 736.
8Sharma A, Sharp D M, Walker L G, et al. Coloreetal MDTs: the team's perspective [J]. Coloreetal Dis, 2008, 10(1): 63-68.
